Stratech Scientific is pleased to announce its acquisition by Europa Biosite’s UK subsidiary, Cambridge Bioscience, the UK’s leading specialist life science distributor.
Integrating with Cambridge Bioscience will bring together two complementary portfolios, creating greater choice for UK life science researchers. Our combined organisation will offer:
• an expanded life science product catalogue
• broader national customer coverage, reaching more academic institutions, biotechnology companies and pharmaceutical partners, and
• enhanced opportunities for existing and new global suppliers through a larger, unified UK commercial platform.
For our customers, nothing changes in how you work with, or order, from us. You will still receive the same products, service, and support you know and have always relied on. This change simply means we can offer you even more choice from a broader product range and will be able to serve you even better.
Sue Hallett, Managing Director of Stratech Scientific, said:
“After 43 years leading Stratech Scientific, I am delighted to announce that we have joined Europa Biosite. Stratech Scientific and Cambridge Bioscience have grown in parallel for decades, sharing the same commitment to enabling scientific discovery. By combining our portfolios and customer reach with Cambridge Bioscience, we will create expanded opportunities for our suppliers while providing our customers with access to a broader range of products and an even stronger level of service. This partnership is built on shared values, experience and a joint commitment to supporting the UK research community.”
Tim Hiddemann, CEO of Europa Biosite, said:
“This acquisition represents an important strategic step for Europa Biosite. Integrating Stratech Scientific’s established product lines and customer relationships with Cambridge Bioscience reinforces our market‑leading position in the UK. It directly aligns with our ambition to offer the most comprehensive life science reagent portfolio in Europe and to be the partner of choice for suppliers and researchers. Expanding our reach and strengthening supplier relationships across key European markets remains a central objective for 2026.”
Thank you for your continued trust in Stratech. We look forward to supporting your research with the same commitment and care as always.
